Suliba^®

Bosutinib

Product Information

Proprietary Name: Suliba®
Generic Name: Bosutinib
Dosage Form: Film-coated Tablet
Strengths: 100 mg
Indications: Chronic Myeloid Leukemia (CML)

Download Leaflet

Oncology

Suliba®

Bosutinib is indicated for the treatment of chronic myeloid leukemia (CML).

Apply for a Job Position

Curious about job opportunities?

Signup for a job

Products

Support

Company

Follow Us

© NanoAlvand. All rights reserved. Powered by ِDGN.